We pipul dɛn kin tink bɔt dayabitis, bɔku pipul dɛn kin tink bɔt insulin injɛkshɔn. Sɔm pipul dɛn kin si dis kin mek dɛn fred smɔl ɛn ivin kin anɔynt am smɔl bikɔs dɛn kin gɛt fɔ injekt am bɔku tɛm insay di de. Bɔt yu no se naw bɔku nyu mɛrɛsin dɛn de we nɔ gɛt insulin, we dɛn kin injɛkt fɔ Tayp 2 Dayabitis? Sɔm pan dɛn tin ya jɔs nid fɔ injɛkt wan tɛm insay di wik. So tide, lɛ wi tɔk smɔl bɔt dɛn nyu, advans mɛrɛsin ya.
Wetin na dis mɛrɛsin? Aw i kin wok?
Di men ɛn pɔpul kayn mɛrɛsin we de na dis kategori na di wan we dɛn kɔl GLP-1 Receptor Agonists . Pan ɔl we di nem kin tan lɛk se i kɔmplikt smɔl, di we aw i de wok rili simpul.
Imajin, wan כmon de we dεn kכl "GLP-1" we dεn kכmכt na wi bכdi nכmal wan. We wi de it, dis ɔmon de sɛn signal to wi pankrias, i se, "Okay, naw shuga de gɛda na di blɔd, so prodyuz di insulin we nid." Dis prɔses kin wik smɔl pan pipul dɛm wae gɛt shuga.
Wetin dis injεkshכn mεdikeshכn dεm we wi de tכk bכt tide de du na fכ wok lεk da nεchכral כmon de εn gi dis εksakεt signal. Dat na:
- I de ɛp di pankrias fɔ mek insulin nɔmɔ we di shuga na di blɔd go ɔp .
- I de kɔntrol di we aw di liva de mek shuga we nɔ nid fɔ de.
- I de mek di rit we di bɔdi de digest slo. Dis kin mek yu fil ful ivin afta yu dɔn it smɔl. Dis kin ɛp fɔ kɔntrol di we aw pɔsin de it pasmak ɛn i kin ɛp fɔ lɛ pɔsin nɔ gɛt bɔku bɔku bɔdi .
Naw lɛ wi tek wan luk pan sɔm difrɛn kayn mɛrɛsin dɛn we de na dis kategori.
| Dulaglutide (Trulisiti) we gɛt fɔ du wit am. | |
|---|---|
| Wetin dis? | Dis na GLP-1 drɔg bak. Di spɛshal tin na dat dɛn jɔs nid fɔ injɛkt am wan tɛm insay di wik . |
| Udat go tek am? | Dɔktɔ dɛn kin se i fɔ big pipul dɛn we gɛt tayp 2 dayabitis we nɔ ebul fɔ kɔntrol dɛn blɔd shuga fayn fayn wan wit ɔda tritmɛnt dɛn. Yu kin yuse am in wan ɔr wit ɔda mɛrɛsin dɛm fɔ gɛt dayabitis (lɛk mɛtfɔmin). |
| Kɔmɔn sayd ɛfɛkt dɛn | Nɔs, vɔmit, bɛlɛ pen, blo, ɛn nɔ kin want fɔ it kin apin di fɔs tɛm. Bɔku tɛm, dɛn tin ya go stɔp insay sɔm dez. |
| Semaglutayd (Ozempik) we dɛn kɔl . | |
|---|---|
| Wetin dis? | Dis na bak wan GLP-1 drɔg we pipul dɛn lɛk we dɛn kin tek wan tɛm insay di wik . Bɔku pipul dɛn na Sri Lanka sabi am wit di nem Ozempic. |
| Udat go tek am? | Dɛn kin gi am to big pipul dɛn we gɛt tayp 2 dayabitis. Dɛn dɔn si se i gɛt ɔda bɛnifit dɛn, mɔ fɔ di wan dɛn we gɛt at sik ɔ kidni sik. Dɔktɔ dɛn kin advays bak fɔ pipul dɛn we fat bikɔs i kin ɛp bak fɔ lɛ dɛn nɔ gɛt bɔku bɔku bɔdi. |
| Kɔmɔn sayd ɛfɛkt dɛn | Nɔs smɔl to smɔl, nɔr kin want fɔ it, yu bɛlɛ kin pen, ɛn pan sɔm pipul dɛm, dɛn yay prɔblɛm (diabetic retinopathy) kin bɔku. So tek tɛm we yu de chɛk yu yay. |
| Tirzepatide (Mɔnjaro) we dɛn kɔl . | |
|---|---|
| Wetin dis? | Dis na mɛrɛsin we ivin nyu ɛn we dɔn go bifo. I de wok lɛk GLP-1 ɛn ɔda ɔmon we dɛn kɔl GIP. So na ‘dual-action’ drɔg. Dɛn kin tek am bak wan tɛm insay di wik. |
| Udat go tek am? | Dɛn kin gi am to big pipul dɛn we gɛt tayp 2 dayabitis. I de sho rili gud rizulyt fɔ kɔntrol di blɔd shuga ɛn fɔ lɛf fɔ it bɔku bɔku it. |
| Kɔmɔn sayd ɛfɛkt dɛn | Lɛk ɔda mɛrɛsin dɛn, yu kin gɛt nɔys, yu bɛlɛ we kin pwɛl, yu nɔ kin want fɔ it, yu bɛlɛ kin pen, ɛn yu kin gɛt kɔnstipɛshɔn. |
Impɔtant: Speshal ɔwe bɔt GLP-1 klas mɛrɛsin dɛn
Stɔdi dɛn we dɛn dɔn du pan animal dɛn dɔn sho se dɛn mɛrɛsin ya gɛt sɔntin fɔ du wit di risk fɔ gɛt tayroyd kansa pan animal dɛn lɛk rat. Bɔt i nɔ klia yet if dis go bi pan mɔtalman . Bɔt fɔ tek tɛm, if yu ɔ sɔmbɔdi na yu famili gɛt tayroyd kansa, yu fɔ rili tɛl yu dɔktɔ bifo yu bigin dis mɛrɛsin.
Wan ɔda mɛrɛsin we de wok difrɛn smɔl
Apat frɔm di GLP-1 klas, ɔda vaysin de we de wok difrɛn we.
| Pramlintide (Symlin) we dɛn kɔl . | |
|---|---|
| Wetin dis? | Dis na wan we we dɛn mek wit wan ɔmon we dɛn kɔl Amylin, we wi pankrias de mek wit insulin. |
| Udat go tek am? | Dɛn kin gi dis to pipul dɛm wae gɛt tayp 1 ɛn tayp 2 dayabitis wae de tek insulin wit it . Dɛn kin yuz am togɛda wit insulin. |
| Aw i de wok | We dɛn tek am wit insulin bifo dɛn it, dɛn tu kin wok togɛda fɔ kɔntrol di blɔd shuga. Lɛk ɔda mɛrɛsin dɛn, dɛn kin mek yu nɔ ebul fɔ digest di it ɛn mek yu fil ful. |
| Kɔmɔn sayd ɛfɛkt dɛn | Di men sayd ɛfɛkt na fɔ nɔs. Fɔ ridyus dis, di dɔktɔ go bigin wit smɔl doz ɛn smɔl smɔl i go inkrisayz di doz. I kin apin bak we i nɔ kin want fɔ it, i kin vɔmit, i kin taya, ɛn i kin gɛt diziz bak. |
If yu de tink bɔt dis mɛrɛsin...
Dɛn mɛrɛsin ya rili advans ɛn dɛn kin wok fayn. Bɔt dɛn nɔ fit fɔ ɔlman. Na yu dɔktɔ nɔmɔ go disayd if dis kayn mɛrɛsin fayn fɔ yu. I go pik di bɛst tritmɛnt afta i dɔn tink bɔt bɔku tin dɛn lɛk aw yu gɛt wɛlbɔdi, aw yu gɛt dayabitis, yu ej, ɛn ɔda sik dɛn.
Ɛspɛshali if yu de plan fɔ gɛt bɛlɛ ɔ yu gɛt bɛlɛ naw, yu fɔ rili tɛl yu dɔktɔ bifo yu yuz ɛni wan pan dɛn mɛrɛsin ya, bikɔs nɔto inɔf stɔdi yet bɔt aw dɛn kin afɛkt uman dɛn we gɛt bɛlɛ.
Mɛsej we dɛn kin kɛr go na os
- Nɔto ɔl di injɛkshɔn dɛn we dɛn kin gi pɔsin we gɛt dayabitis na insulin. Naw, advans mɛrɛsin dɛn de we dɛn kin tek wan tɛm insay di wik, lɛk Ozempic ɛn Trulicity.
- Dɛn mɛrɛsin ya nɔ jɔs de kɔntrol di blɔd shuga, bɔt dɛn kin ɛp yu bak fɔ lɛf fɔ it bɔku bɔku it bay we dɛn de mek yu fil ful.
- Sɔm bad tin dɛn lɛk fɔ nɔs, vɔmit, ɛn fɔ nɔ want fɔ it kin bɔku we yu fɔs bigin fɔ tek dis mɛrɛsin. Bɔku tɛm, dɛn kin go afta sɔm dez. Bɔt if dɛn kɔntinyu fɔ de ɔ dɛn bad bad wan, tɛl yu dɔktɔ.
- Bifo yu bigin fɔ tek ɛni nyu mɛrɛsin, mek shɔ se yu tɛl yu dɔktɔ bɔt di sik we yu gɛt naw ɛn di famili mɛdikal istri (espɛshali tayroyd kansa).
- Nɔ disayd if dis mɛrɛsin fayn fɔ yu bay we yu de luk na di intanɛt. Na di dɔktɔ we de chɛk yu nɔmɔ fɔ disayd fɔ du dat.
💬 Comments (0)
No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.
Ad yu kɔmɛnt